Who classifications of pregnancy with heart diseases

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
I now have all the information needed for a comprehensive answer.

WHO (Modified) Classification of Pregnancy with Heart Disease

The modified WHO (mWHO) classification of maternal cardiovascular risk is the most widely used and ESC-endorsed system for counseling pregnant women with heart disease. It was developed by the World Health Organization and refined in the 2018 ESC Guidelines on cardiovascular diseases during pregnancy.

Principles of the Classification

ClassRisk Description
INo detectable increased risk of maternal mortality and no or mild increase in morbidity
IISmall increased risk of maternal mortality or moderate increase in morbidity
IIISignificantly increased risk of maternal mortality or severe morbidity. Expert counseling required. Intensive specialist cardiac and obstetric monitoring needed throughout pregnancy, childbirth, and the puerperium
IVExtremely high risk of maternal mortality or severe morbidity - pregnancy contraindicated. If pregnancy occurs, termination should be discussed. If continued, care as for Class III

Application: Conditions by Class

mWHO Class I - No detectable increased risk

  • Uncomplicated, small, or mild pulmonary stenosis / mitral valve prolapse
  • Successfully repaired simple lesions (ASD, VSD, PDA, anomalous pulmonary venous drainage)
  • Isolated atrial or ventricular ectopic beats

mWHO Class II - Small increased risk

  • Unoperated ASD or VSD
  • Repaired tetralogy of Fallot
  • Most supraventricular arrhythmias
  • Turner syndrome without aortic dilation
  • NYHA class I-II with good ventricular function

mWHO Class III - Significantly increased risk (expert center required)

  • Mild left ventricular impairment (EF < 45%)
  • Hypertrophic cardiomyopathy
  • Native or tissue valve disease not in Class I or IV (e.g., mild mitral stenosis, moderate aortic stenosis)
  • Marfan or other heritable thoracic aortic disease (HTAD) without aortic dilation
  • Aorta < 45 mm in bicuspid aortic valve pathology
  • Repaired cyanotic heart disease
  • Moderate left ventricular impairment (EF 30-45%)
  • Mechanical valve
  • Systemic right ventricular impairment (mild-moderate)
  • Fontan circulation (uncomplicated)
  • Moderate mitral stenosis
  • Severe asymptomatic aortic stenosis
  • Moderate aortic dilation (40-45 mm in Marfan/HTAD; 45-50 mm in bicuspid AV)

mWHO Class IV - Pregnancy contraindicated

  • Pulmonary arterial hypertension (any cause) - maternal mortality up to 50%
  • Severe systemic ventricular dysfunction (EF < 30% or NYHA class III-IV)
  • Previous peripartum cardiomyopathy with any residual LV impairment
  • Severe mitral stenosis
  • Severe symptomatic aortic stenosis
  • Systemic right ventricle with moderate or severely decreased function
  • Severe aortic dilation: > 45 mm in Marfan/HTAD, > 50 mm in bicuspid AV, Turner syndrome ASI < 25 mm/m²; tetralogy of Fallot > 50 mm
  • Severe coarctation of the aorta
  • Fontan with any complication
  • Vascular Ehlers-Danlos

Maternal Cardiac Event Rates by Class

ClassMaternal Cardiac Event RateFollow-up VisitsCare Setting
I2.5% - 5.9%Once or twiceLocal hospital
II5.7% - 10.5%Once per trimesterLocal hospital
III10% - 19%Every 2 monthsReferral hospital
IV19% - 27%Monthly or every 2 monthsExpert center for pregnancy and cardiac disease

Key Clinical Points

  1. Class IV conditions warrant pre-pregnancy counseling and, if pregnancy occurs, early discussion of termination given prohibitive risk.
  2. Class III and IV patients must be managed by a multidisciplinary team - cardiologist, maternal-fetal medicine specialist, anesthesia, and often cardiac surgery.
  3. Maternal and neonatal adverse events correlate - cyanotic heart disease increases miscarriage risk and neonatal complications.
  4. CARPREG II scoring (published more recently) supplements WHO class by adding 10 predictors including process-of-care factors (e.g., late presentation to prenatal care), achieving a c-statistic of 0.77.
  5. For most pregnant women with heart disease, vaginal delivery is recommended unless obstetric or specific cardiac indications exist.

High-risk conditions with specific estimated mortality:
ConditionEstimated Maternal Mortality
Aortic stenosis~5%
Severe coarctation of the aorta~5%
Marfan syndrome10-20%
Peripartum cardiomyopathy15-60%
Severe pulmonary hypertension~50%
Tetralogy of Fallot (repaired)~10%
Sources: Creasy & Resnik's Maternal-Fetal Medicine, Table 52.2 & 52.3; 2018 ESC Guidelines on Cardiovascular Diseases During Pregnancy (Regitz-Zagrosek et al., Eur Heart J. 2018;39:3165-3241)
This is a shared conversation. Sign in to Orris to start your own chat.